BioSpace News Archive

InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces the initiation of enrollment and successful completion of the first cases of the Company’s U.S. registration C-Guardian trial of CGuard EPS.

July 23, 2021
·
5 min read
Genetown

EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of the Moderna COVID-19 Vaccine in Adolescents (12-17 Years of Age) in the European Union

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending marketing authorization for Moderna’s COVID-19 vaccine (Spikevax) to include adolescents 12 years of age and older.

July 23, 2021
·
6 min read
Dental Laboratory Welders Market: An increase in dental implant procedures is projected to drive the market

Welding between abutment elements during metal framework construction or even after ceramics application has been used by majority of dentists to alleviate problems related to laboratory distortions that are reflected in prosthesis’ mismatch in the marginal area.

July 23, 2021
·
4 min read
Computer-Assisted Orthopedic Surgical Equipment Demand to Surpass 5%, as AI Integration in Healthcare Continues, Fact.MR

Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global market for computer-assisted orthopedic surgery market is poised to expand at a CAGR of 5.5% over the forecast period 2021-2031, owing to the rising technological advancements in the healthcare sector.

July 23, 2021
·
7 min read
Biological Autoimmune Therapeutics Market: North America to Capture Major Share of Global Market

Biologics are perfect for the treatment of perpetual issues including hormonal insufficiencies, malignancy, neurological scatters, autoimmune clutters, and other basic conditions

July 23, 2021
·
5 min read
Deals

Acasti Pharma Schedules Conference Call for August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics

Acasti Pharma Inc. announces it will host a business update conference call on Wednesday, August 4 th at 1:00 PM ET to discuss the planned acquisition of Grace Therapeutics, Inc.

July 23, 2021
·
10 min read
Deals

ImmixBio Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

Immix Biopharma, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering (“IPO”) of its common stock.

July 23, 2021
·
1 min read
GNTbm’s Trial on New Epigenetic Drug Generates Hope for Patients with Breast Cancer

New clinical trial by Taiwan’s GNT Biotech & Medicals Corporation (GNTbm) combines therapeutic options for more effective treatment of breast cancer

July 23, 2021
·
3 min read
Research illuminates earliest part of phase separation

St. Jude scientists study how phase separation begins on a microsecond time scale, showing how the earliest events with individual molecules impact assembly speed.

July 23, 2021
·
4 min read
Business

Tetra Therapeutics Announces Retirement of Mark Gurney and Names Chad Coberly Chief Executive Officer in Planned Succession

Tetra Therapeutics announced changes to its executive team as the company marks one year since the close of its merger with Shionogi & Co., Ltd..

July 23, 2021
·
3 min read